Selexipag

ATC B01AC27 · 11 markets · 145 records

Selexipag 11 markets · 145 records Forms
Filters

US 36 records · 12 shown of 19 Source openFDA NDC Directory · Data as of 2026-10-23

  • 1.6 mgtabletUPTRAVIManufacturer: Zydus Lifesciences Limited、Manufacturer: Zydus Pharmaceuticals (USA)… also in AU·TW·GB
    +4Other 4 marketsCASGESFR
  • 1.4 mgtabletUPTRAVIManufacturer: Zydus Lifesciences Limited、Manufacturer: Zydus Pharmaceuticals (USA)… also in AU·TW·GB
    +4Other 4 marketsCASGESFR
  • 1.2 mgtabletUPTRAVIManufacturer: Zydus Lifesciences Limited、Manufacturer: Zydus Pharmaceuticals (USA)… also in AU·TW·GB
    +4Other 4 marketsCASGESFR
  • 1 mgtabletUPTRAVIManufacturer: Zydus Lifesciences Limited、Manufacturer: Zydus Pharmaceuticals (USA)… also in AU·TW·GB
    +3Other 3 marketsCASGFR
  • 0.8 mgtabletUPTRAVIManufacturer: Zydus Lifesciences Limited、Manufacturer: Zydus Pharmaceuticals (USA)… also in AU·TW·CA
    +3Other 3 marketsSGESFR
  • 0.6 mgtabletUPTRAVIManufacturer: Zydus Lifesciences Limited、Manufacturer: Zydus Pharmaceuticals (USA)… also in AU·TW·CA
    +3Other 3 marketsSGESFR
  • 0.4 mgtabletUPTRAVIManufacturer: Zydus Lifesciences Limited、Manufacturer: Zydus Pharmaceuticals (USA)… also in AU·TW·CA
    +3Other 3 marketsSGESFR
  • 0.2 mgtabletUPTRAVIManufacturer: Zydus Lifesciences Limited、Manufacturer: Zydus Pharmaceuticals (USA)… also in AU·TW·CA
    +3Other 3 marketsSGESFR
  • 0.15 mgtabletUPTRAVI
  • 0.1 mgtabletUPTRAVI
  • 1.6 mgcapsuleManufacturer: Excella GmbH & Co. KG ×9
  • 1.8 mg/10 mLinjectionUPTRAVI
Other strengths: 7 · 1 dosage forms Otras concentraciones: 7 · 1 formas farmacéuticas 其余规格 7 个 · 涉及 1 种剂型 其餘規格 7 個 · 涉及 1 種劑型

AU 18 records · 8 shown of 8 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

  • 1.6 mgtabletUPTRAVIUPTRAVI selexipag 1600 microgram film-coated tablet blister pack also in US·TW·GB
    +4Other 4 marketsCASGESFR
    unknown
  • 1.4 mgtabletUPTRAVIUPTRAVI selexipag 1400 microgram film-coated tablet blister pack also in US·TW·GB
    +4Other 4 marketsCASGESFR
    unknown
  • 1.2 mgtabletUPTRAVIUPTRAVI selexipag 1200 microgram film-coated tablet blister pack also in US·TW·GB
    +4Other 4 marketsCASGESFR
    unknown
  • 1 mgtabletUPTRAVIUPTRAVI selexipag 1000 microgram film-coated tablet blister pack also in US·TW·GB
    +3Other 3 marketsCASGFR
    unknown
  • 0.8 mgtabletUPTRAVIUPTRAVI selexipag 800 microgram film-coated tablet blister pack also in US·TW·CA
    +3Other 3 marketsSGESFR
    unknown
  • 0.6 mgtabletUPTRAVIUPTRAVI selexipag 600 microgram film-coated tablet blister pack also in US·TW·CA
    +3Other 3 marketsSGESFR
    unknown
  • 0.4 mgtabletUPTRAVIUPTRAVI selexipag 400 microgram film-coated tablet blister pack also in US·TW·CA
    +3Other 3 marketsSGESFR
    unknown
  • 0.2 mgtabletUPTRAVIUPTRAVI selexipag 200 microgram film-coated tablet blister pack also in US·TW·CA
    +3Other 3 marketsSGESFR
    unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

TW 16 records · 8 shown of 8 Source 衛生福利部食品藥物管理署(TFDA)全部藥品許可證資料集 · Data as of 2026-10-22

  • 1.6 mgtabletUPTRAVIUPTRAVI (CM) film-coated tablets 200 mcg、優拓比膜衣錠1600微克、尚達利膜衣錠1600微克 also in US·AU·GB
    +4Other 4 marketsCASGESFR
  • 1.4 mgtabletUPTRAVIUPTRAVI (CM) film-coated tablets 200 mcg、優拓比膜衣錠1400微克、尚達利膜衣錠1400微克 also in US·AU·GB
    +4Other 4 marketsCASGESFR
  • 1.2 mgtabletUPTRAVIUPTRAVI (CM) film-coated tablets 200 mcg、優拓比膜衣錠1200微克、尚達利膜衣錠1200微克 also in US·AU·GB
    +4Other 4 marketsCASGESFR
  • 1 mgtabletUPTRAVIUPTRAVI (CM) film-coated tablets 200 mcg、優拓比膜衣錠1000微克、尚達利膜衣錠1000微克 also in US·AU·GB
    +3Other 3 marketsCASGFR
  • 0.8 mgtabletUPTRAVIUPTRAVI (CM) film-coated tablets 200 mcg、優拓比膜衣錠800微克、尚達利膜衣錠800微克 also in US·AU·CA
    +3Other 3 marketsSGESFR
  • 0.6 mgtabletUPTRAVIUPTRAVI (CM) film-coated tablets 200 mcg、優拓比膜衣錠600微克、尚達利膜衣錠600微克 also in US·AU·CA
    +3Other 3 marketsSGESFR
  • 0.4 mgtabletUPTRAVIUPTRAVI (CM) film-coated tablets 200 mcg、優拓比膜衣錠400微克、尚達利膜衣錠400微克 also in US·AU·CA
    +3Other 3 marketsSGESFR
  • 0.2 mgtabletUPTRAVIUPTRAVI (CM) film-coated tablets 200 mcg、優拓比膜衣錠200微克、尚達利膜衣錠200微克 also in US·AU·CA
    +3Other 3 marketsSGESFR

GB 8 records · 4 shown of 4 Source NHSBSA dm+d · Data as of 2026-10-19 · some records have no stated strength

  • 1.6 mgtabletUptravi 1,600microgram tablets also in US·AU·TW
    +4Other 4 marketsCASGESFR
  • 1.4 mgtabletUptravi 1,400microgram tablets also in US·AU·TW
    +4Other 4 marketsCASGESFR
  • 1.2 mgtabletUptravi 1,200microgram tablets also in US·AU·TW
    +4Other 4 marketsCASGESFR
  • 1 mgtabletUptravi 1,000microgram tablets also in US·AU·TW
    +3Other 3 marketsCASGFR
4 records · 0 manufacturers 4 registros · 0 fabricantes 4 个记录 · 0 个厂家 4 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Uptravi 200microgram tablets ×1Uptravi 400microgram tablets ×1Uptravi 600microgram tablets ×1Uptravi 800microgram tablets ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

CA 8 records · 8 shown of 8 Source Health Canada Drug Product Databas · Data as of 2026-10-23

SG 8 records · 8 shown of 8 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

ES 8 records · 8 shown of 8 Source CIMA (AEMPS) · Data as of live

HK 8 records · 0 shown of 0 Source 衞生署藥物辦公室(香港)註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

8 records · 0 manufacturers 8 registros · 0 fabricantes 8 个记录 · 0 个厂家 8 個記錄 · 0 個廠商

FR 8 records · 8 shown of 8 Source Base de données publique des médic · Data as of 2026-11-03

  • 1.6 mgtabletUPTRAVI 1600 microgrammes, comprimé pelliculé also in US·AU·TW
    +4Other 4 marketsGBCASGES
  • 1.4 mgtabletUPTRAVI 1400 microgrammes, comprimé pelliculé also in US·AU·TW
    +4Other 4 marketsGBCASGES
  • 1.2 mgtabletUPTRAVI 1200 microgrammes, comprimé pelliculé also in US·AU·TW
    +4Other 4 marketsGBCASGES
  • 1 mgtabletUPTRAVI 1000 microgrammes, comprimé pelliculé also in US·AU·TW
    +3Other 3 marketsGBCASG
  • 0.8 mgtabletUPTRAVI 800 microgrammes, comprimé pelliculé also in US·AU·TW
    +3Other 3 marketsCASGES
  • 0.6 mgtabletUPTRAVI 600 microgrammes, comprimé pelliculé also in US·AU·TW
    +3Other 3 marketsCASGES
  • 0.4 mgtabletUPTRAVI 400 microgrammes, comprimé pelliculé also in US·AU·TW
    +3Other 3 marketsCASGES
  • 0.2 mgtabletUPTRAVI 200 microgrammes, comprimé pelliculé also in US·AU·TW
    +3Other 3 marketsCASGES

MX 1 records · 0 shown of 0 Source COFEPRIS · Data as of annual · some records have no stated strength

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

Side-by-side table

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.